RecruitingNCT06067295
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Sponsor
University of Southern California
Enrollment
300 participants
Start Date
Feb 21, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria3
- Men of all racial and ethnic groups 18 years of age or older
- Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
- Prior participation on clinical trials is allowed
Exclusion Criteria2
- Inability to give informed consent
- Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06067295
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
NCT048575021 location
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
NCT047882771 location
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
NCT062162491 location
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
NCT071640271 location